07 Oct, 2019 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria
Posted at 10:55h
in Capella
On October 7, 2019, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyria.
-
- Akin Akinc, Ph.D., General Manager, Givosiran
- Srikanth Nagalla, M.D., M.S., Associate Professor of Internal Medicine, Medical Director of Blood Disorders Clinic, Program Director of Hematology/Oncology Fellowship, UT Southwestern Medical Center
- Jae Kim, M.D., Vice President, Clinical Development
